Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in ...

Normal Course: Two-thirds of patients with skin lesions will have lichen planus for 1 to 2 years with spontaneous clearing in the second year. One in five will have a recurrence of lichen planus.

Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...